StanleySOstrowMD

PubMed

• Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies.
  Madajewicz, S., Hentschel, P., Burns, P., Caruso, R., Fiore, J., Fried, M., Malhotra, H., Ostrow, S., Sugarman, S., Viola, M.> ;J Clin Oncol. 2000 Oct 15
• Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.
  Gerad, H., van Echo, D. A., Whitacre, M., Ashman, M., Helrich, M., Foy, J., Ostrow, S., Wiernik, P. H., Aisner, J.> ;Cancer. 1984 Jun 15
• Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.
  Fuks, J. Z., Aisner, J., Van Echo, D. A., Schipper, H., Levitt, M., Ostrow, S., Wiernik, P. H.> ;J Clin Oncol. 1983 May
• Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.
  Fuks, J. Z., Egorin, M. J., Aisner, J., Van Echo, D. A., Ostrow, S., Bachur, N. R., Wiernik, P. H.> ;Cancer Chemother Pharmacol. 1983
• 3 citations
  The Management of Nonseminomatous Testicular Cancer: Current Therapy and Future Directions
  Stanley S. Ostrow> ;The American Journal of the Medical Sciences. 1983 Jan 1
• A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
  Fuks, J. Z., Aisner, J., Carney, D. N., Van Echo, D. A., Ostrow, S. S., Ihde, D. C., Wiernik, P. H.> ;Am J Clin Oncol. 1982 Feb
• Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival.
  Ostrow, S. S., Diggs, C. H., Sutherland, J. C., Gustafson, J., Wiernik, P. H.> ;Cancer Treat Rep. 1981 Nov 01
• Causes of death in patients with non-Hodgkin's lymphoma.
  Ostrow, S., Diggs, C. H., Sutherland, J., Wiernik, P. H.> ;Cancer. 1981 Aug 1
• Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer.
  Ostrow, S., Van Echo, D., Whitacre, M., Aisner, J., Simon, R., Wiernik, P. H.> ;Cancer Treat Rep. 1981 Mar 01
• Leptomeningeal carcinomatosis in small cell carcinoma of the lung.
  Aisner, J., Ostrow, S., Govindan, S., Wiernik, P. H.> ;Med Pediatr Oncol. 1981
• High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity.
  Ostrow, S., Egorin, M. J., Hahn, D., Markus, S., Aisner, J., Chang, P., LeRoy, A., Bachur, N. R., Wiernik, P. H.> ;Cancer Treat Rep. 1981 Jan 01
• Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.
  Fuks, J. Z., Egorin, M. J., Aisner, J., Ostrow, S. S., Klein, M. E., Bachur, N. R., Colvin, M., Wiernik, P. H.> ;Cancer Chemother Pharmacol. 1981
• Nodular lymphoma. Prolongation of survival by complete remission.
  Diggs, C. H., Wiernik, P. H., Ostrow, S. S.> ;Cancer Clin Trials. 1981
• Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.
  Ostrow, S., Egorin, M. J., Hahn, D., Markus, S., Leroy, A., Chang, P., Klein, M., Bachur, N. R., Wiernik, P. H.> ;Cancer. 1980 Oct 15
• Peripheral neuropathy after cis-platinum (II) (DDP) therapy.
  Reinstein, L., Ostrow, S. S., Wiernik, P. H.> ;Arch Phys Med Rehabil. 1980 Jun
• High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
  Ostrow, S., Egorin, M., Aisner, J., Bachur, N., Wiernik, P. H.> ;Cancer Clin Trials. 1980
• Quantitative changes in cis-dichlorodiammineplatinum(II) speciation in excreted urine with time after iv infusion in man: methods of analysis, preliminary studies, and...
  LeRoy, A. F., Wehling, M., Gormley, P., Egorin, M., Ostrow, S., Bachur, N., Wiernik, P.> ;Cancer Treat Rep. 1980 Jan
• Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival.
  Aisner, J., Aisner, S. C., Ostrow, S., Govindan, S., Mummert, K., Wiernik, P.> ;Acta Cytol. 1979 Jul 01
• Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.
  Ostrow, S., Hahn, D., Wiernik, P. H., Richards, R. D.> ;Cancer Treat Rep. 1978 Oct
• Join now to see all